Swayne DE - Search Results

1

Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity.

Pletnev AG, Swayne DE, Speicher J, Rumyantsev AA, Murphy BR. Pletnev AG, et al. Among authors: swayne de. Vaccine. 2006 Sep 29;24(40-41):6392-404. doi: 10.1016/j.vaccine.2006.06.008. Epub 2006 Jun 21. Vaccine. 2006. PMID: 16831498

2

Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate.

Chen H, Subbarao K, Swayne D, Chen Q, Lu X, Katz J, Cox N, Matsuoka Y. Chen H, et al. Vaccine. 2003 May 16;21(17-18):1974-9. doi: 10.1016/s0264-410x(02)00809-5. Vaccine. 2003. PMID: 12706686

3

Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate.

Chen H, Matsuoka Y, Swayne D, Chen Q, Cox NJ, Murphy BR, Subbarao K. Chen H, et al. Vaccine. 2003 Oct 1;21(27-30):4430-6. doi: 10.1016/s0264-410x(03)00430-4. Vaccine. 2003. PMID: 14505926

4

Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.

Suguitan AL Jr, McAuliffe J, Mills KL, Jin H, Duke G, Lu B, Luke CJ, Murphy B, Swayne DE, Kemble G, Subbarao K. Suguitan AL Jr, et al. Among authors: swayne de. PLoS Med. 2006 Sep;3(9):e360. doi: 10.1371/journal.pmed.0030360. PLoS Med. 2006. PMID: 16968127 Free PMC article.

5

Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.

Desheva JA, Lu XH, Rekstin AR, Rudenko LG, Swayne DE, Cox NJ, Katz JM, Klimov AI. Desheva JA, et al. Among authors: swayne de. Vaccine. 2006 Nov 17;24(47-48):6859-66. doi: 10.1016/j.vaccine.2006.06.023. Epub 2006 Jun 28. Vaccine. 2006. PMID: 17050041

6

Development and evaluation of an Influenza virus subtype H7N2 vaccine candidate for pandemic preparedness.

Pappas C, Matsuoka Y, Swayne DE, Donis RO. Pappas C, et al. Among authors: swayne de. Clin Vaccine Immunol. 2007 Nov;14(11):1425-32. doi: 10.1128/CVI.00174-07. Epub 2007 Oct 3. Clin Vaccine Immunol. 2007. PMID: 17913860 Free PMC article.

7

Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.

Jadhao SJ, Achenbach J, Swayne DE, Donis R, Cox N, Matsuoka Y. Jadhao SJ, et al. Among authors: swayne de. Vaccine. 2008 Mar 25;26(14):1742-50. doi: 10.1016/j.vaccine.2008.01.036. Epub 2008 Feb 13. Vaccine. 2008. PMID: 18336962

8

A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.

Joseph T, McAuliffe J, Lu B, Vogel L, Swayne D, Jin H, Kemble G, Subbarao K. Joseph T, et al. Virology. 2008 Aug 15;378(1):123-32. doi: 10.1016/j.virol.2008.05.021. Epub 2008 Jun 27. Virology. 2008. PMID: 18585748 Free PMC article.

9

A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.

Min JY, Vogel L, Matsuoka Y, Lu B, Swayne D, Jin H, Kemble G, Subbarao K. Min JY, et al. J Virol. 2010 Nov;84(22):11950-60. doi: 10.1128/JVI.01305-10. Epub 2010 Sep 1. J Virol. 2010. PMID: 20810733 Free PMC article.

10

Domestic goose as a model for West Nile virus vaccine efficacy.

Sá E Silva M, Ellis A, Karaca K, Minke J, Nordgren R, Wu S, Swayne DE. Sá E Silva M, et al. Among authors: swayne de. Vaccine. 2013 Feb 4;31(7):1045-50. doi: 10.1016/j.vaccine.2012.12.044. Epub 2012 Dec 28. Vaccine. 2013. PMID: 23277093

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters